Rare specimen access Leverage Celerity Biosciences extensive bio specimen services and access to retrospective and prospective sample programs as a value proposition for clients requiring well-curated tissue samples to enable translational research and biomarker discovery.

Integrated pathology Target biotechnology and pharma clients seeking end-to-end pathology solutions, including immunohistochemistry, molecular pathology, conventional pathology, and digital image analysis, all under ISO 15189 accredited facilities for quality and regulatory assurance.

Sequencing capacity Position the company as a flexible outsourcing partner with access to Illumina and Ion Torrent platforms, along with Archer panels, to support customers needing diverse sequencing workflows and turnaround times without significant capital investment.

Digital diagnostics Highlight capabilities in digital image analysis to support scalable image-based biomarker quantification and remote pathology workflows, appealing to CROs and biotechs expanding digital pathology programs.

Growth-friendly positioning Given lean headcount and modest revenue, pursue partnerships and contract-based collaborations with larger labs and contract research organizations to scale services, cross-sell biorepository and lab services, and accelerate market penetration.